Compare PCAR & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCAR | IDXX |
|---|---|---|
| Founded | 1905 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.5B | 57.1B |
| IPO Year | N/A | 1991 |
| Metric | PCAR | IDXX |
|---|---|---|
| Price | $124.52 | $635.91 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 10 |
| Target Price | $115.38 | ★ $697.50 |
| AVG Volume (30 Days) | ★ 3.2M | 503.5K |
| Earning Date | 01-27-2026 | 02-02-2026 |
| Dividend Yield | ★ 2.18% | N/A |
| EPS Growth | N/A | ★ 22.59 |
| EPS | 4.51 | ★ 13.08 |
| Revenue | ★ $28,444,800,000.00 | $4,303,702,000.00 |
| Revenue This Year | $1.68 | $10.42 |
| Revenue Next Year | $10.82 | $9.01 |
| P/E Ratio | ★ $27.63 | $48.90 |
| Revenue Growth | N/A | ★ 10.42 |
| 52 Week Low | $84.65 | $356.14 |
| 52 Week High | $125.36 | $769.98 |
| Indicator | PCAR | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 67.19 | 27.70 |
| Support Level | $120.88 | $687.46 |
| Resistance Level | $125.36 | $705.82 |
| Average True Range (ATR) | 2.63 | 16.14 |
| MACD | -0.11 | -5.83 |
| Stochastic Oscillator | 88.71 | 13.75 |
Paccar is a leading manufacturer of medium- and heavy-duty trucks under the premium nameplates Kenworth and Peterbilt, which are primarily sold in the Americas and Australia, and DAF, which primarily services Europe and South America. The trucks segment (74% sales) goes to market through a network of 2,200 independent dealers. Paccar maintains an internal finance subsidiary that provides retail and wholesale financing for customers and dealers (6% sales). In recent years, Paccar has aggressively expanded its parts business (20% of sales), including engines, axles, and transmissions for its own truck brands as well as independent producers. The company commands approximately 30% of the Class 8 market share in North America and 15% of the heavy-duty market share in Europe.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.